Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver

NCT04546022 is registered in ClinicalTrials.gov with National Defense Medical Center, Taiwan as lead sponsor.

NCT NCT04546022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04546022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver
Lead sponsor
National Defense Medical Center, Taiwan
Phase
Phase 1/2
Overall status
Completed
Start date
July 5, 2007
Completion date
October 31, 2018
Enrollment
210 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

galactose single point (gsp), residual liver function